Physician profile
Robert Patrick Davis
NPI 1417299561
$1,446.48
in general payments reported to CMS, 2019-2025
8 companies · $502 in 2025
The $502 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $243 · 2024: $701 · 2025: $502.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $941 · Consulting Fee: $263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $940.63 |
| Consulting Fee | $262.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $780.24 | 2022-2025 | Atriclip Laa Exclusion System, Synergy Ablation System |
| Abbott Laboratories | $473.07 | 2022-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Abiomed | $72.32 | 2024-2025 | Impella |
| Zimmer Biomet Holdings, INC. | $51.76 | 2024-2025 | Sternalock Blu System, A&E Medical / Sternalock Xp Rigid Fixation System |
| Lemaitre Vascular, INC. | $24.08 | 2025 | Hydro Lemaitre Valvulotome |
| Artivion, INC. | $23.80 | 2024 | On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Bioglue Surgical Adhesive, Cryovalve Sg Pulmonary Human Heart Valve |
| Peerless Surgical INC. | $21.21 | 2024 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.